Prescription Drug, N.B. Reg. 84-170

Section 20.1

Cite as Prescription Drug, N.B. Reg. 84-170, s. 20.1 · current to September 15, 2026 · read from New Brunswick Acts and Regulations on November 16, 2026

The text

(1) Where a prescription is for an entitled service that is an interchangeable pharmaceutical product specified by product name and the prescriber has not prohibited substitution and the participating provider elects to substitute an interchangeable pharmaceutical product other than the one specified in the prescription, the participating provider shall advise the beneficiary that an interchangeable pharmaceutical product other than the one specified in the prescription will be dispensed under the programme unless the beneficiary does not wish to receive the substituted interchangeable pharmaceutical product. (2) Where the beneficiary does not wish to receive the substituted interchangeable pharmaceutical product referred to in subsection (1), the participating provider (a) may dispense the interchangeable pharmaceutical product specified in the prescription, (b) shall advise the beneficiary of the beneficiary’s liability to pay an authorized charge set out in section 20.3, and (c) may collect from the beneficiary the authorized charge set out in section 20.3.
Read the Prescription Drug on the Province's website ↗

Made under Prescription Drug Payment Act, c. P-15.01.